{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:00:58Z","timestamp":1791216058056,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T00:00:00Z","timestamp":1624320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.ijcard.2021.06.032","type":"journal-article","created":{"date-parts":[[2021,6,19]],"date-time":"2021-06-19T10:49:33Z","timestamp":1624099773000},"page":"121-126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Recognition of pre-hypertrophic cardiac involvement in Fabry Disease based on automated electrocardiographic measures"],"prefix":"10.1016","volume":"338","author":[{"given":"Mehdi","family":"Namdar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Richardot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Johner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipen","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Nordbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iacopo","family":"Olivotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Macfarlane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ijcard.2021.06.032_bb0005","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ymgme.2018.02.014","article-title":"Fabry disease revisited: management and treatment recommendations for adult patients","volume":"123","author":"Ortiz","year":"2018","journal-title":"Mol. Genet. Metab."},{"issue":"3","key":"10.1016\/j.ijcard.2021.06.032_bb0010","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ymgme.2018.06.004","article-title":"European expert consensus statement on therapeutic goals in Fabry disease","volume":"124","author":"Wanner","year":"2018","journal-title":"Mol. Genet. Metab."},{"issue":"7","key":"10.1016\/j.ijcard.2021.06.032_bb0015","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jacc.2020.12.024","article-title":"Cardiac involvement in Fabry disease: JACC review topic of the week","volume":"77","author":"Pieroni","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2021.06.032_bb0020","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fcvm.2016.00007","article-title":"Electrocardiographic changes and arrhythmia in Fabry disease","volume":"3","author":"Namdar","year":"2016","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.ijcard.2021.06.032_bb0025","first-page":"100454","article-title":"The effect of enzyme replacement therapy on clinical outcomes in male patients with Fabry disease: a systematic literature review by a European panel of experts","volume":"19","author":"Germain","year":"2019","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"5","key":"10.1016\/j.ijcard.2021.06.032_bb0030","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.amjcard.2009.10.056","article-title":"PQ interval in patients with Fabry disease","volume":"105","author":"Namdar","year":"2010","journal-title":"Am. J. Cardiol."},{"issue":"4","key":"10.1016\/j.ijcard.2021.06.032_bb0035","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.amjcard.2011.09.052","article-title":"Value of electrocardiogram in the differentiation of hypertensive heart disease, hypertrophic cardiomyopathy, aortic stenosis, amyloidosis, and Fabry disease","volume":"109","author":"Namdar","year":"2012","journal-title":"Am. J. Cardiol."},{"issue":"6","key":"10.1016\/j.ijcard.2021.06.032_bb0040","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1136\/hrt.2010.211789","article-title":"Electrocardiographic changes in early recognition of Fabry disease","volume":"97","author":"Namdar","year":"2011","journal-title":"Heart"},{"issue":"16","key":"10.1016\/j.ijcard.2021.06.032_bb0045","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1136\/heartjnl-2015-308897","article-title":"The value of ECG parameters as markers of treatment response in Fabry cardiomyopathy","volume":"102","author":"Schmied","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2021.06.032_bb0050","series-title":"Comprehensive Electrocardiology","first-page":"483","article-title":"The normal electrocardiogram and vectorcardiogram","author":"Macfarlane","year":"2010"},{"issue":"4","key":"10.1016\/j.ijcard.2021.06.032_bb0055","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1055\/s-0038-1634799","article-title":"Methodology of ECG interpretation in the Glasgow program","volume":"29","author":"Macfarlane","year":"1990","journal-title":"Methods Inf. Med."},{"issue":"6","key":"10.1016\/j.ijcard.2021.06.032_bb0060","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/0002-8703(68)90035-5","article-title":"A point-score system for the ECG diagnosis of left ventricular hypertrophy","volume":"75","author":"Romhilt","year":"1968","journal-title":"Am. Heart J."},{"issue":"6","key":"10.1016\/j.ijcard.2021.06.032_bb0065","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.117.007168","article-title":"Cardiac phenotype of prehypertrophic Fabry disease","volume":"11","author":"Nordin","year":"2018","journal-title":"Circ. Cardiovasc. Imag."},{"issue":"4","key":"10.1016\/j.ijcard.2021.06.032_bb0070","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.118.008424","article-title":"Predictors of clinical evolution in prehypertrophic Fabry disease","volume":"12","author":"Camporeale","year":"2019","journal-title":"Circ. Cardiovasc. Imag."},{"issue":"4","key":"10.1016\/j.ijcard.2021.06.032_bb0075","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.119.009067","article-title":"Mapping phenotype development in Fabry disease","volume":"12","author":"Augusto","year":"2019","journal-title":"Circ. Cardiovasc. Imag."},{"issue":"2","key":"10.1016\/j.ijcard.2021.06.032_bb0080","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.stemcr.2019.07.004","article-title":"A human stem cell model of Fabry disease implicates LIMP-2 accumulation in cardiomyocyte pathology","volume":"13","author":"Birket","year":"2019","journal-title":"Stem Cell Rep."},{"issue":"1","key":"10.1016\/j.ijcard.2021.06.032_bb0085","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.hrthm.2019.07.019","article-title":"The electrocardiogram in the diagnosis and management of patients with hypertrophic cardiomyopathy","volume":"17","author":"Finocchiaro","year":"2019","journal-title":"Heart Rhythm."},{"issue":"1","key":"10.1016\/j.ijcard.2021.06.032_bb0090","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/anec.12323","article-title":"R-peak time: an electrocardiographic parameter with multiple clinical applications","volume":"21","author":"Perez-Riera","year":"2016","journal-title":"Ann. Noninvasive Electrocardiol."},{"issue":"12","key":"10.1016\/j.ijcard.2021.06.032_bb0095","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.119.009430","article-title":"Myocardial storage, inflammation, and cardiac phenotype in Fabry disease after one year of enzyme replacement therapy","volume":"12","author":"Nordin","year":"2019","journal-title":"Circ. Cardiovasc. Imag."},{"issue":"8 Pt 2","key":"10.1016\/j.ijcard.2021.06.032_bb0100","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.jcmg.2018.03.020","article-title":"Proposed stages of myocardial phenotype development in Fabry disease","volume":"12","author":"Nordin","year":"2019","journal-title":"JACC Cardiovasc. Imaging"},{"issue":"Suppl. 1","key":"10.1016\/j.ijcard.2021.06.032_bb0105","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/17431380410032553","article-title":"Cellular basis and mechanism underlying normal and abnormal myocardial repolarization and arrhythmogenesis","volume":"36","author":"Antzelevitch","year":"2004","journal-title":"Ann. Med."},{"key":"10.1016\/j.ijcard.2021.06.032_bb0110","article-title":"The myocardial phenotype of Fabry disease pre-hypertrophy and pre-detectable storage","volume":"Jun 8;jeaa101","author":"Augusto","year":"2020","journal-title":"Eur. Heart J. Cardiovasc. Imag."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527321010305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527321010305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:54:23Z","timestamp":1759092863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527321010305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":22,"alternative-id":["S0167527321010305"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2021.06.032","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recognition of pre-hypertrophic cardiac involvement in Fabry Disease based on automated electrocardiographic measures","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2021.06.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}